FAF1 Gene Involvement in Pituitary Corticotroph Tumors

Abstract

Cushing’s disease (CD) is caused by rare pituitary corticotroph tumors that lead to corticotropin (ACTH) excess. Variants in FAF1, a pro-apoptotic protein involved in FAS-induced cell death, have been implicated in malignant disorders but the involvement of FAF1 in pituitary tumors has not been studied. Genetic data from patients with CD were reviewed for variants in FAF1 gene. Knockout mice (KO) were followed to assess the development of any pituitary disorder or cortisol excess. AtT-20 cells were used to study the effects of the variants of interest on ACTH secretion and cell proliferation. Three variants of interest were identified in 5 unique patients, two of which had rare allele frequency in genomic databases and were predicted to be likely pathogenic. KO mice were followed over time and no difference in their length/weight was noted. Additionally, KO mice did not develop any pituitary lesions and retained similar corticosterone secretion with wild type. AtT-20 cells transfected with FAF1 variants of interest or WT expression plasmids showed no significant difference in cell death or Pomc gene expression. However, in silico prediction models suggested significant differences in secondary structures of the produced proteins. In conclusion, we identified two FAF1 variants in patients diagnosed with CD with a potential pathogenic effect on the protein function and structure. Our in vitro and in vivo studies did not reveal an association of FAF1 defects with pituitary tumorigenesis and further studies may be needed to understand any association.

Key words

Cushing’s disease - FAF1 - cell apoptosis

Publikationsverlauf

Eingereicht: 01. Juni 2023

Angenommen nach Revision: 11. Oktober 2023

Artikel online veröffentlicht:
08. Dezember 2023

• References

• 1 Asa SL, Mete O, Perry A. et al. Overview of the 2022 WHO classification of pituitary tumors. Endocr Pathol 2022; 33: 6-26
• 2 Tatsi C, Stratakis CA. The genetics of pituitary adenomas. J Clin Med 2019; 9: 30
• 3 Chu K, Niu X, Williams LT. A Fas-associated protein factor, FAF1, potentiates Fas-mediated apoptosis. Proc Natl Acad Sci U S A 1995; 92: 11894-11898
• 4 Ryu SW, Lee SJ, Park MY. et al. Fas-associated factor 1, FAF1, is a member of Fas death-inducing signaling complex. J Biol Chem 2003; 278: 24003-24010
• 5 Menges CW, Altomare DA, Testa JR. FAS-associated factor 1 (FAF1): diverse functions and implications for oncogenesis. Cell Cycle 2009; 8: 2528-2534
• 6 Elmetwali T, Young LS, Palmer DH. Fas-associated factor (Faf1) is a novel CD40 interactor that regulates CD40-induced NF-kappaB activation via a negative feedback loop. Cell Death Dis 2014; 5: e1213
• 7 Chen L, Tian X, Li W. et al. Expressions of Fas/DcR3 and RGD-FasL mediated apoptosis in pituitary adenomas. Neurol India 2009; 57: 28-30
• 8 Stratakis CA. Diagnosis and clinical genetics of Cushing syndrome in pediatrics. Endocrinol Metab Clin North Am 2016; 45: 311-328
• 9 Nieman LK, Biller BM, Findling JW. et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008; 93: 1526-1540
• 10 Tatsi C, Pankratz N, Lane J. et al. Large genomic aberrations in corticotropinomas are associated with greater aggressiveness. J Clin Endocrinol Metab 2019; 104: 1792-1801
• 11 Bartolomucci A, Pederzani T, Sacerdote P. et al. Behavioral and physiological characterization of male mice under chronic psychosocial stress. Psychoneuroendocrinology 2004; 29: 899-910
• 12 Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408
• 13 Zhou X, Zheng W, Li Y. et al. I-TASSER-MTD: a deep-learning-based platform for multi-domain protein structure and function prediction. Nat Protoc 2022; 17: 2326-2353
• 14 Zheng W, Zhang C, Li Y. et al. Folding non-homologous proteins by coupling deep-learning contact maps with I-TASSER assembly simulations. Cell Rep. Methods 2021; 1
• 15 Yang J, Zhang Y. I-TASSER server: new development for protein structure and function predictions. Nucleic Acids Res 2015; 43: W174-W181
• 16 Zhang Y, Skolnick J. TM-align: a protein structure alignment algorithm based on the TM-score. Nucleic Acids Res 2005; 33: 2302-2309
• 17 Hyland PL, Lin SW, Hu N. et al. Genetic variants in fas signaling pathway genes and risk of gastric cancer. Int J Cancer 2014; 134: 822-831
• 18 Bonjoch L, Franch-Exposito S, Garre P. et al. Germline mutations in FAF1 are associated with hereditary colorectal cancer. Gastroenterology 2020; 159: e227
• 19 Jaita G, Candolfi M, Zaldivar V. et al. Estrogens up-regulate the Fas/FasL apoptotic pathway in lactotropes. Endocrinology 2005; 146: 4737-4744
• 20 Uhlen M, Fagerberg L, Hallstrom BM. et al. Proteomics. Tissue-based map of the human proteome. Science 2015; 347: 1260419